Therma Bright Inc (THRM) - Cash Flow Conversion Efficiency

Latest as of October 2025: 0.026x

Based on the latest financial reports, Therma Bright Inc (THRM) has a cash flow conversion efficiency ratio of 0.026x as of October 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-38.76K ≈ $-28.04K USD) by net assets (CA$-1.52 Million ≈ $-1.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Therma Bright Inc - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Therma Bright Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read THRM total debt and obligations for a breakdown of total debt and financial obligations.

Therma Bright Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Therma Bright Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Cariboo Rose Resources Ltd
V:CRB
0.180x
Netcall plc
LSE:NET
0.012x
GIGLIO GROUP S.P.A. O.N.
F:5JR
N/A
Range International Ltd
AU:RAN
-0.462x
James Latham PLC
LSE:LTHM
0.049x
Australian Silica Quartz Group Ltd
F:4B4
-0.076x
Superior Industries International
NYSE:SUP
0.139x
Supply@Me Capital PLC
LSE:SYME
0.084x

Annual Cash Flow Conversion Efficiency for Therma Bright Inc (2001–2025)

The table below shows the annual cash flow conversion efficiency of Therma Bright Inc from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Therma Bright Inc stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-07-31 CA$-1.57 Million
≈ $-1.13 Million
CA$-146.53K
≈ $-106.00K
0.094x +112.28%
2024-07-31 CA$1.32 Million
≈ $958.00K
CA$-1.01 Million
≈ $-730.10K
-0.762x +98.43%
2023-07-31 CA$44.79K
≈ $32.40K
CA$-2.17 Million
≈ $-1.57 Million
-48.555x -3410.13%
2022-07-31 CA$2.75 Million
≈ $1.99 Million
CA$-3.80 Million
≈ $-2.75 Million
-1.383x +36.29%
2021-07-31 CA$1.32 Million
≈ $951.41K
CA$-2.86 Million
≈ $-2.07 Million
-2.171x -363.35%
2020-07-31 CA$223.97K
≈ $162.01K
CA$-104.94K
≈ $-75.91K
-0.469x -170.73%
2019-07-31 CA$-286.40K
≈ $-207.18K
CA$-189.72K
≈ $-137.24K
0.662x -86.82%
2018-07-31 CA$-71.59K
≈ $-51.79K
CA$-359.89K
≈ $-260.34K
5.027x +2417.45%
2017-07-31 CA$-893.85K
≈ $-646.59K
CA$-178.49K
≈ $-129.11K
0.200x +601500.19%
2016-07-31 CA$-1.63 Million
≈ $-1.18 Million
CA$54.00
≈ $39.06
0.000x -100.22%
2015-07-31 CA$-1.42 Million
≈ $-1.03 Million
CA$-21.43K
≈ $-15.50K
0.015x +50.83%
2014-07-31 CA$-5.52 Million
≈ $-3.99 Million
CA$-55.16K
≈ $-39.90K
0.010x -33.21%
2013-07-31 CA$-5.62 Million
≈ $-4.06 Million
CA$-84.10K
≈ $-60.84K
0.015x +22658.84%
2012-07-31 CA$-6.61 Million
≈ $-4.78 Million
CA$-435.00
≈ $-314.67
0.000x -97.60%
2011-07-31 CA$-5.83 Million
≈ $-4.22 Million
CA$-16.00K
≈ $-11.57K
0.003x -78.02%
2009-07-31 CA$-5.03 Million
≈ $-3.64 Million
CA$-62.68K
≈ $-45.34K
0.012x -87.91%
2008-07-31 CA$-3.54 Million
≈ $-2.56 Million
CA$-365.58K
≈ $-264.45K
0.103x -61.80%
2007-07-31 CA$-2.00 Million
≈ $-1.44 Million
CA$-539.12K
≈ $-389.99K
0.270x -69.93%
2006-07-31 CA$-1.46 Million
≈ $-1.06 Million
CA$-1.31 Million
≈ $-950.53K
0.898x +73.98%
2005-07-31 CA$-991.06K
≈ $-716.92K
CA$-511.69K
≈ $-370.15K
0.516x -95.60%
2004-07-31 CA$-117.47K
≈ $-84.98K
CA$-1.38 Million
≈ $-997.57K
11.739x +2050.43%
2002-07-31 CA$1.61 Million
≈ $1.16 Million
CA$-968.11K
≈ $-700.31K
-0.602x +22.24%
2001-07-31 CA$633.46K
≈ $458.24K
CA$-490.32K
≈ $-354.69K
-0.774x --

About Therma Bright Inc

V:THRM Canada Medical Devices
Market Cap
$2.52 Million
CA$3.48 Million CAD
Market Cap Rank
#29430 Global
#1467 in Canada
Share Price
CA$0.06
Change (1 day)
+9.09%
52-Week Range
CA$0.01 - CA$0.11
All Time High
CA$0.87
About

Therma Bright Inc. acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace. Its products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical he… Read more